Evidence map›Paper›PMID 30632103›Full record

ArticleJournal of general internal medicine2019

Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization.

Sarah E Wakeman, Nancy A Rigotti, Yuchiao Chang, Grace E Herman, Ann Erwin, Susan Regan, Joshua P Metlay

Abstract read
In one paragraph

Article in Journal of general internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. The HERSAmerican journal of public health · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Sarah E WakemanDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA. swakeman@partners.org.
Nancy A RigottiDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Yuchiao ChangDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Grace E HermanDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Ann ErwinMassachusetts General Physicians Organization, Boston, MA, USA.
Susan ReganDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Joshua P MetlayDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundComponents of substance use disorder (SUD) treatment have been shown to reduce inpatient and emergency department (ED) utilization. However, integrated treatment using pharmacotherapy and recovery coaches in primary care has not been studied.

objectiveTo determine whether integrated addiction treatment in primary care reduces inpatient and ED utilization and improves outpatient engagement.

designA retrospective cohort study comparing patients in practices with and without integrated addiction treatment including pharmacotherapy and recovery coaching during a staggered roll-out period.

participantsA propensity score matched sample of 2706 adult primary care patients (1353 matched pairs from intervention and control practices) with a SUD diagnosis code, excluding cannabis or tobacco only, matched on baseline utilization.

interventionA multi-modal strategy that included forming interdisciplinary teams of local champions, access to addiction pharmacotherapy, counseling, and recovery coaching. Control practices could refer patients to an addiction treatment clinic offering pharmacotherapy and behavioral interventions. MAIN MEASURES: The number of inpatient admissions, hospital bed days, ED visits, and primary care visits. KEY

resultsDuring the follow-up period, there were fewer inpatient days among the intervention group (997 vs. 1096 days with a mean difference of 7.3 days per 100 patients, p = 0.03). The mean number of ED visits was lower for the intervention group (36.2 visits vs. 42.9 per 100 patients, p = 0.005). There was no difference in the mean number of hospitalizations. The mean number of primary care visits was higher for the intervention group (317 visits vs. 270 visits per 100 patients, p < 0.001). Intervention practices had a greater increase in buprenorphine and naltrexone prescribing.

conclusionsIn a non-randomized retrospective cohort study, integrated addiction pharmacotherapy and recovery coaching in primary care resulted in fewer hospital days and ED visits for patients with SUD compared to similarly matched patients receiving care in practices without these services.

Indexed as

AdultBuprenorphineCohort StudiesCounselingDelivery of Health Care, IntegratedEmergency Service, HospitalFemaleHospitalizationHumansInpatientsMaleMiddle AgedPrimary Health CareRetrospective StudiesSubstance-Related DisordersTreatment OutcomeBuprenorphineaddictionbuprenorphineintegrated addiction treatmentprimary carerecovery coachsubstance use disorderutilization

Identifiers

PMID30632103
PMCPMC6544728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.